Business Description
Founded in 2010 and based in Wuhan, China, YZY Biopharma is a biotechnology company focused on developing bispecific antibody treatments. Its pipeline targets a range of serious conditions, including several types of cancer, fluid complications arising from tumors, eye diseases driven by abnormal blood vessel growth, hemophilia, and inflammatory bowel disease.
